Traditional Indian plants as the source of compounds to treat a respiratory viral infection

Vidya Venkateswaran; Vinduja Vasudevan; Aradhana Karthikeyan; Vrithi Sundararaman; Ineya Madhavan; Samantha Prathab; Aakash John Peter; Nagasathiya Krishnan; Velmurugan Devadasan; Pachaiappan Raman

Vidya Venkateswaran ⁽¹⁾ , Vinduja Vasudevan ⁽²⁾ , Aradhana Karthikeyan ⁽³⁾ , Vrithi Sundararaman ⁽⁴⁾ , Ineya Madhavan ⁽⁵⁾ , Samantha Prathab ⁽⁶⁾ , Aakash John Peter ⁽⁷⁾ , Nagasathiya Krishnan ⁽⁸⁾ , Velmurugan Devadasan ⁽⁹⁾ , Pachaiappan Raman ⁽¹⁰⁾

(1) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(2) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(3) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(4) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(5) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(6) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(7) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(8) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(9) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India ,

(10) Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur - 603203, Tamilnadu, India, India

Issue
Vol. 12 No. 1 (2021): Volume 12 Issue 1

Keywords:

Viral infection, Chloroquine, Traditional medicine, Coronavirus, Natural compounds

PDF LaTeX HTML ePUB

Abstract

Since December 2019 world news broadcasted stories of a deadly disease caused by SARS CoV-19, which is a single-stranded positive-sense RNA virus that replicates in the cytoplasm of infected cells. Coronaviruses (CoVs) and the associated severe acquired respiratory syndrome (SARS - CoV) are potential agents to infect the respiratory tract of humans and animals. Much scientific effort has been focused on the development of vaccine and medicines to protect future outbreaks. However, the chances to rapidly develop an effective vaccine are difficult now. Due to the sudden and explosive emergence of the disease, empirical strategies have been used to treat the patients. The increasing demand for natural products as an alternative therapy for pandemic viral diseases has encouraged research into the pharmacological importance of bioactive compounds from plants, especially Indian herbs. Ethnopharmacological studies have been extremely relevant to discover promising drugs for the treatment of viral diseases. This review is intended to focus on the traditionally practised Indian medicinal plants and bioactive compounds with antiviral properties used for the treatment of respiratory associated viral infections and other retroviral infections. It may lead us to develop a broad spectrum of anti-viral for the prevention and control of these viral pathogens in the current situation.

Full text article

Generated from XML file

References

Aanouz, I., Belhassan, A., Eikhatabi, K., Lakhlifi, T., Bouachire, M. 2020. Moroccan medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular structure and dynamics.

Betty, A. T., Matumba, E. M. G., Mukvevho 1915. Oleanolic acid and its derivatives: Biological activities and therapeutic potential in chronic diseases. Molecules, 22.

Cheng, H.-Y. 2006. Ent-epiafzelchin-(4α8)-epiafzele extracted from Cassia javanica inhibits herpes simplex virus type 2 replication. Journal of Medical Microbiology, 55(2):201–206.

Ciesek, S. 2011. The Green Tea Polyphenol, Epigallocatechin-3-Gallate, Inhibits Hepatitis C Virus Entry. Journal of Hepatology, 54(6):1947– 1955.

Els, K., Vijgen, L., Pannecouque, C., Damm, E. V., Peumans, W., Egberink, H., Balzarini, J., Ranst, M. V. 2007. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Research, 75(3):179– 187.

Fanales-Belasio, E., Raimondo, M., Suligoi, B. 2010. HIV virus and pathogenicity. Ann Ist Super Sanità, 46(1):5–14.

Fox, R. I. 1993. Mechanism of Action of Hydroxychloroquine as an Anti-rheumatic Drug. Seminars in Arthritis and Rheumatism, 23(2):82–91.

Haid, S. 2012. A plant derived flavonoid inhibits entry of all HIV genotypes into human hepatocytes. Journal ofGastroenterology, 143(1):213– 222.

Helfer, M., Koppensteiner, H., Schneider, M. 2014. The Root Extract of the Medicinal Plant Pelargonium sidoides is a Potent HIV-1 Attachment Inhibitor. PLOS One, 9(1):87487–87487.

Hernandez, S., Ramirez, M., Gomez, S., Mendoza, R., Camacho 2016. Phytochemical characterization and effect of Calendula officinalis, Hypercum perforatum and Salvia officinalis infusions on obesity associated cardiovascular risk. Medicinal Chemistry Research, 25:163–172.

Hoever, G. 2005. Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS - Coronavirus. Journal of Medicinal Chemistry, 48(4):1256–1259.

Jadhav, P., Kapoor, N., Thomas, B., Lal, H., Sagar, N. K. 2012. Antiviral potential of selected Indian medicinal (ayurvedic) plants against herpes simplex virus 1 and 2. North America Journal of Medical Sciences, 4(12):641–647.

Jiaa, B., Yub, D., Yua, G., Chenga, Y., Wanga, Y., Yia, X., Lib, X., Wanga, Y. 2008. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53- dependent manner. Biomedicine and Pharmacotherapy, 103:746–754.

Jin, Z., Du, X., Xu, Y., Rao, Z., Yang, H. 2020. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582:289–293.

Kamaraj, C., Kaushik, N. K., Rahuman, A. A., Mohanakrishnan, D., Bagavan, A., Elango, G., Zahir, A. A., Santhoshkumar, T., Marimuthu, S., Jayaseelan, C., Kirthi, A. V., Rajakumar, G., Velayutham, K., Sahal, D. 2012. Antimalarial activities of medicinal plants traditionally used in the villages of Dharmapuri regions of South India. Journal of Ethnopharmacology, 141(3):796–802.

Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartatisuhartati, S., Soetjipto 2020. Potential inhibitor of COVID-19 main protease from several medicinal plant compounds by molecular docking study. Preprints, pages 1–14.

Kudo, E. 2013. Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells. Bioorganic and Medicinal Chemistry Letters, (3):606–609.

Li, Shi-You 2005. Identification of natural compounds with antiviral activities against SARS- associated coronavirus. Antiviral research, 67:18– 23.

Martin, J., Vincent, E., Bergeron, S., Benjannet, Bobbie, R., Erickson, P. E., Rollin, T. G., Ksiazek, Nabil, G., Seidah, Stuart, T., Nichol 2005. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Journal of Virology, 2(69):1–10.

Martinson, J. A., Montoya, C. J., Usuga, X., Ronquillo, R., Landay, A. L., Desai, S. N. 2014. Chloroquine modulates HIV1 induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation. Antimicrobial Agents and Chemotherapy, 54:871–881.

Muralidharan, N., Sakthivel, R., Velmurugan, D., Gromiha, M. M. 2020. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV- 2 protease against COVID-19. Journal of Biomolecular structure and dynamics.

Muthul, C. 2006. Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu. Journal of Ethnobiology Ethnomedicine, 2:43–43.

Neeraj, K., Sethiya, Shrihari, H., Mishra 2014. Simultaneous HPTLC analysis of Ursolic acid, Betulinic acid, Stigmasterol and Lupeol for the identification of four medicinal plants commonly available in the Indian market as Shankhpushpi. Journal of chromatographic science, 53(5):1–8.

Peng, Z., Yang, X.-L., Zheng-Li-Shi 2020. A pneumonia outbreak associated with a new corona virus of probable bat origin. Nature, 579:270–273.

Ranavelli, N., Santos, K. P., Santos, L. B., Motta, L. B., Lago, J. H. G., Furlan, C. M. 2015. Alkaloids from Croton echinicarpus Baill: Anti-HIV potential. South African Journal of Botany, 102(1):153– 156.

Sampangi-Ramaiah, R. M. H., Vishwakarma, R. U., Shaanker 2020. Molecular docking analysis of selected natural products from plants for inhibition of SARS-COV-2 main protease. Current science, 118(7):1087–1092.

Savarino, A., John, R., Boelaert, A., Cassone, Giancariomajori, R., Cauda 2003. Effects of chloroquine on viral infections: an old drug against today’s diseases. The Lancet Infectious Diseases, 3(11):722– 727.

Sivasankari, B., Anandharaj, M., Gunasekaran, P. 2014. An ethnobotanical study of indigenous knowledge on medicinal plants used by the village peoples of Thoppampatti. Journal of Ethanopharmacology, 153(2):408–423.

Song, W. Y., Ma, Y. B., Bai, X., Zhang, X. M., Gu, Q., Zhang, Y. J., Zhou, J., Chen, J., Planta Medica 2007. Two new compounds and anti-HIV constituents from Illicium verum. 73:372–375.

Zhang, T. Y., Zhong, B. 2020. Meeting the Poten-tial Emergency Global Drug Supply Challenge of Hydroxychloroquine for COVID-19. Medicine in Drug Discovery. 100036.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z. 2020. A retrospective study on clinical course and risk factors for mortality in 191 adult patients from Jinyintan Hospital and Wuhan pulmonary Hospital published in the Lancet. Lancet, 395(10229):1054– 1062.